FDA.reportPublic FDA data

NDC 62022-711-50 - CODRIX

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
62022-711
Requested NDC
62022-711-50
Package NDCs from labels
62022-711-01, 62022-711-05, 62022-711-50
Manufacturer
Andrx Laboratories, Inc.
Effective date
2007-09-18
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CODRIX™ (Acetaminophen and Codeine Phosphate Tablets, USP)Andrx Laboratories, Inc.2007-09-18HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62022-711-01CODRIX100 in 1 BOTTLETABLET1002
62022-711-05CODRIX500 in 1 BOTTLETABLET5002
62022-711-50CODRIX1000 in 1 BOTTLETABLET10002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62022-711CODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]23 package rows20070928_31d4cf3e-a903-4a43-bd44-73fbffc424b3.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
acetaminophenACTIVE INGREDIENT362O9ITL9DCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
codeine phosphateACTIVE INGREDIENTGSL05Y1MN6CODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
acetaminophenACTIVE MOIETY362O9ITL9DCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
codeineACTIVE MOIETYQ830PW7520CODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
Colloidal silicon dioxideINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
croscarmellose sodiumINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
crospovidoneINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
magnesium stearateINACTIVE INGREDIENT70097M6I30CODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
microcrystalline celluloseINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
povidoneINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
pregelatinized starchINACTIVE INGREDIENTCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2
stearic acidINACTIVE INGREDIENT4ELV7Z65APCODRIX (ACETAMINOPHEN AND CODEINE PHOSPHATE) TABLET [ANDRX LABORATORIES, INC.]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
43075396-AE1F-0485-DECE-903D821D946731d4cf3e-a903-4a43-bd44-73fbffc424b32007-09-18Warnings, Adverse reactionsExact identifier
spl id: 43075396-AE1F-0485-DECE-903D821D9467
spl set id: 31d4cf3e-a903-4a43-bd44-73fbffc424b3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.